K780939 is an FDA 510(k) clearance for the BARD-PARKER ARTERIAL MONITORING SYSTEM. This device is classified as a Arterial Blood Sampling Kit (Class I - General Controls, product code CBT).
Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Washington, US). The FDA issued a Cleared decision on July 17, 1978, 39 days after receiving the submission on June 8, 1978.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.1100. This Product Code Has Been Established In Accordance With The May 20, 1997, Guidance Entitled, Convenience Kits Interim Regulatory Guidance, Found At Www.fda.gov/cdrh/ode/convkit.html. This Type Of Convenience Kit, As Listed In The Guidance Above, Is Under Enforcement Discretion, And Does Not Require A Premarket Notification (510(k)) To Market If It Meets All Criteria In The Guidance..
| 510(k) Number | K780939 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 08, 1978 |
| Decision Date | July 17, 1978 |
| Days to Decision | 39 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | — |
| Product Code | CBT — Arterial Blood Sampling Kit |
| Device Class | Class I - General Controls |
| CFR Regulation | 21 CFR 868.1100 |
| Definition | This Product Code Has Been Established In Accordance With The May 20, 1997, Guidance Entitled, Convenience Kits Interim Regulatory Guidance, Found At Www.fda.gov/cdrh/ode/convkit.html. This Type Of Convenience Kit, As Listed In The Guidance Above, Is Under Enforcement Discretion, And Does Not Require A Premarket Notification (510(k)) To Market If It Meets All Criteria In The Guidance. |